Search Results - "Woody, George E"

Advances in the treatment of opioid use disorders [version 1; peer review: 3 approved] by Woody, George E

“…The development of medications for treating persons with opioid use disorders has expanded the number of evidence-based treatment options, particularly for…”
Get full text

Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth by Subramaniam, Geetha A., M.D, Warden, Diane, Ph.D., M.B.A, Minhajuddin, Abu, Ph.D, Fishman, Marc J., M.D, Stitzer, Maxine L., Ph.D, Adinoff, Bryon, M.D, Trivedi, Madhukar, M.D, Weiss, Roger, M.D, Potter, Jennifer, Ph.D, Poole, Sabrina A., M.S, Woody, George E., M.D

“…Objective To examine predictors of opioid abstinence in buprenorphine/naloxone (Bup/Nal)-assisted psychosocial treatment for opioid-dependent youth. Method…”
Get full text

Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials by Murphy, Sean M, Jeng, Philip J, Poole, Sabrina A, Jalali, Ali, Vocci, Frank J, Gordon, Michael S, Woody, George E, Polsky, Daniel

“…Persons with an opioid use disorder (OUD) who were incarcerated face many challenges to remaining abstinent; concomitantly, opioid-overdose is the leading…”
Get full text

Commentary on Farnum et al.: Agonist maintenance in Ukraine—ambivalence, success and moving forward by Woody, George E.

Get full text

Medication Treatment for Opioid-Addicted Youth-What Are We Waiting for? by Woody, George E, Fishman, Marc

“…Woody et al offer insights about medication treatment for opiod-addicted youth. The prevalence, magnitude, and consequences of the current opioid epidemic…”
Get full text

Current Progress in Opioid Treatment by Woody, George E

Get full text

A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United States by Cicero, Theodore J, Adams, Edgar H, Geller, Anne, Inciardi, James A, Muñoz, Alvaro, Schnoll, Sidney H, Senay, Edward C, Woody, George E

“…Tramadol HCl, marketed as Ultram® in the USA, was introduced as a non-scheduled drug in April 1995 based on the assumption that the risk of abuse was…”
Get full text

Factors contributing to dropping out from and returning to HIV treatment in an inner city primary care HIV clinic in the United States by Pecoraro, Anna, Royer-Malvestuto, Charlotte, Rosenwasser, Beth, Moore, Kevin, Howell, Allen, Ma, Michelle, Woody, George E.

“…Although advances in pharmacotherapy have enabled people living with HIV/AIDS to live longer, fuller lives, some leave medical care, resulting in sub-optimal…”
Get full text

Economic Costs of Nonmedical Use of Prescription Opioids by Hansen, Ryan N, Oster, Gerry, Edelsberg, John, Woody, George E, Sullivan, Sean D

“…OBJECTIVESAlthough the economic costs of substance misuse have been extensively examined in the published literature, information on the costs of nonmedical…”
Get full text

HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial by Woody, George E, Bruce, Douglas, Korthuis, P Todd, Chhatre, Sumedha, Poole, Sabrina, Hillhouse, Maureen, Jacobs, Petra, Sorensen, James, Saxon, Andrew J, Metzger, David, Ling, Walter

“…Compare HIV injecting and sex risk in patients being treated with methadone (MET) or buprenorphine-naloxone (BUP). Secondary analysis from a study of liver…”
Get full text

Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior—Outcomes of a randomized trial by Otiashvili, David, Piralishvili, Gvantsa, Sikharulidze, Zura, Kamkamidze, George, Poole, Sabrina, Woody, George E

“…Abstract Aims Determine the extent to which buprenorphine injectors continue treatment with buprenorphine-naloxone or methadone, and the impact of these…”
Get full text

Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial by Woody, George E, Poole, Sabrina A, Subramaniam, Geetha, Dugosh, Karen, Bogenschutz, Michael, Abbott, Patrick, Patkar, Ashwin, Publicker, Mark, McCain, Karen, Potter, Jennifer Sharpe, Forman, Robert, Vetter, Victoria, McNicholas, Laura, Blaine, Jack, Lynch, Kevin G, Fudala, Paul

“…CONTEXT The usual treatment for opioid-addicted youth is detoxification and counseling. Extended medication-assisted therapy may be more helpful. OBJECTIVE To…”
Get full text

Antagonist Models for Treating Persons With Substance use Disorders by Woody, George E.

“…This paper provides an overview on the status of antagonist models for treating patients with substance use disorders. It begins with an overview describing…”
Get full text

You Can't Be in Recovery If You Are on Medication: A Concept Worth Retiring by Woody, George E.

Get full text

Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies by Bisaga, Adam, Mannelli, Paolo, Sullivan, Maria A., Vosburg, Suzanne K., Compton, Peggy, Woody, George E., Kosten, Thomas R.

“…Background and Objectives Opioid use disorder (OUD) is a chronic condition with potentially severe health and social consequences. Many who develop moderate to…”
Get full text

Drug Treatment as HIV Prevention: A Research Update by Metzger, David S, Woody, George E, OʼBrien, Charles P

“…Drug use continues to be a major factor fueling the global epidemic of HIV infection. This article reviews the current literature on the ability of drug…”
Get full text

Adjunctive psychosocial interventions for opioid use disorder by Woody, George E

Get full text

Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial by Mannelli, Paolo, Wu, Li-Tzy, Peindl, Kathleen S, Swartz, Marvin S, Woody, George E

“…Abstract Background The approval of extended release injectable naltrexone (XR-NTX; Vivitrol ) has introduced a new option for treating opioid addiction, but…”
Get full text

Treatment use and barriers among adolescents with prescription opioid use disorders by Wu, Li-Tzy, Blazer, Dan G, Li, Ting-Kai, Woody, George E

“…Abstract Background This study examined national trends, patterns, correlates, and barriers to substance abuse treatment use by adolescents aged 12–17 years…”
Get full text

The Science and Practice of Medication-Assisted Treatments for Opioid Dependence by Pecoraro, Anna, Ma, Michelle, Woody, George E.

“…This paper briefly reviews the evolution of opioid addiction treatment from humanitarian to scientific and evidence-based, the evidence bases supporting major…”
Get full text